STOCK TITAN

Common stock holder (Nasdaq: IONS) files to sell 3,977 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder has filed a notice of proposed sale of 3,977 shares of common stock through broker Stifel Nicolaus & Company on or about 01/22/2026, with the shares listed on Nasdaq. These shares were acquired on 01/13/2026 as restricted stock units from the issuer, with equity compensation recorded on 01/07/2026. The filing also notes that the same shareholder sold 44,199 shares of common stock on 01/07/2026 for gross proceeds of $3,756,915.00 and 16,777 shares on 11/25/2025 for gross proceeds of $1,342,160.00. The shareholder represents that they are not aware of any undisclosed material adverse information about the issuer’s operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many IONS shares are covered by this Form 144 notice?

The notice covers the proposed sale of 3,977 shares of common stock through broker Stifel Nicolaus & Company.

What type of IONS securities are being sold under this Form 144?

The filing relates to common stock, listed on the Nasdaq exchange.

When were the IONS shares being sold under Form 144 acquired?

The 3,977 shares were acquired on 01/13/2026 as restricted stock units from the issuer, tied to equity compensation dated 01/07/2026.

What is the approximate planned sale date for the IONS shares in this Form 144?

The approximate sale date for the 3,977 shares of common stock is listed as 01/22/2026.

What prior IONS share sales by this holder are disclosed in the Form 144?

The filing shows sales of 44,199 shares on 01/07/2026 for gross proceeds of $3,756,915.00 and 16,777 shares on 11/25/2025 for gross proceeds of $1,342,160.00.

Does the Form 144 state whether the IONS shares were acquired as compensation?

Yes. The 3,977 shares to be sold were acquired as restricted stock units from the issuer, with the nature of payment shown as equity compensation.
Ionis Pharmaceuticals

NASDAQ:IONS

IONS Rankings

IONS Latest News

IONS Latest SEC Filings

IONS Stock Data

12.87B
160.75M
0.65%
108.48%
6.59%
Biotechnology
Pharmaceutical Preparations
Link
United States
CARLSBAD